All Mayo does is take what Anavex has published, regurgitates it, and pastes it into a nice little website. If you notice, he throws in a page or two on Cognition Therapeutics just to make it look like he’s not Missling’s shill.
Putting people on ignore who have a different opinion than your own is a sign of weakness and is potentially perilous. But of course this message board seems to be all about everybody agreeing on the approved narrative or else, which is also potentially perilous. The motto could be “love it or sell it”. There are people here I disagree with but I read their posts anyway. I think a healthy debate is better than demonizing people with a different opinion but I guess I’m old school.
We’ll see what happens. If Blarcamesine is approved by the EMA, I’ll be the first to offer my congratulations. And if it’s not approved, I’ll be the first to say I told you so.
Market Data 
Markets 
